{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:37:58Z","timestamp":1792607878596,"version":"4.5.0"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Multiple sclerosis (MS) is a debilitating neurodegenerative disorder characterized by axonal damage, demyelination, and perivascular inflammatory lesions in the white matter of the central nervous system (CNS). Kynurenine pathway (KP), which is the major route of tryptophan (TRP) metabolism, generates a variety of neurotoxic as well as neuroprotective compounds, affecting MS pathology and the severity of impairments. Alterations in KP have been described not only in MS, but also in various psychiatric and neurodegenerative diseases. The purpose of this systematic review is to investigate the previously reported dysregulation of KP and differences in its metabolites and enzymes in patients with MS compared to healthy control subjects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Electronic databases of PubMed, Scopus, Cochrane Database of Systematic Reviews, and Web of Science were searched to identify studies measuring concentrations of KP metabolites and enzymes in MS\u00a0patients and control subjects. The following metabolites and enzymes implicated in the KP were investigated: TRP, kynurenine (KYN), kynurenic acid (KYNA), quinolinic acid (QUIN), picolinic acid (PIC), hydroxyindoleacetic acid (HIAA), indoleamine 2,3-dioxygenase (IDO), kynurenine aminotransferase (KAT), and their related ratios.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>Ten studies were included in our systematic review. Our review demonstrates that IDO expression is reduced in the peripheral blood mononuclear cells (PBMCs) of MS patients compared to healthy controls. Also, increased levels of QUIN and QUIN\/KYNA in the serum and cerebrospinal fluid (CSF) of MS patients is observed. Differences in levels of other metabolites and enzymes of KP are also reported in some of the reviewed studies, however there are discrepancies among the included reports.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The results of this investigation suggest a possible connection between alterations in the levels of\u00a0KP metabolite or\u00a0enzymes\u00a0and MS. QUIN levels in CSF were higher in MS patients than in healthy controls, suggesting that QUIN may be involved in the pathogenesis of MS. The data indicate that differences in the serum\/blood or CSF levels of certain KP metabolites and enzymes could potentially be used to differentiate between MS patients and control subjects.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.1013784","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T07:26:53Z","timestamp":1667374013000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review"],"prefix":"10.3389","volume":"13","author":[{"given":"Mobina","family":"Fathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Vakili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Yaghoobpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arian","family":"Tavasol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Jazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Mohamadkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andis","family":"Klegeris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"McElhinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahedeh","family":"Mafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Hajiesmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Sayehmiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130715","article-title":"Indoleamine 2, 3 dioxygenase (IDO) expression and activity in relapsing-remitting multiple sclerosis","volume":"10","author":"Mancuso","year":"2015","journal-title":"PloS One"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01184.x","article-title":"Epidemiology of headache in Europe","volume":"13","author":"Stovner","year":"2006","journal-title":"Eur J Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838371","article-title":"Activation of myelin reactive T cells in multiple sclerosis: A possible role for T cell degeneracy","volume":"38","author":"Stinissen","year":"2008","journal-title":"Eur J Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/cells9061564","article-title":"Kynurenines in the pathogenesis of multiple sclerosis: Therapeutic perspectives","volume":"9","author":"Biernacki","year":"2020","journal-title":"Cells"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1988.tb03663.x","article-title":"Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations","volume":"78","author":"Beck","year":"1988","journal-title":"Acta Neurol Scand"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.3390\/ijms21082665","article-title":"Cerebrospinal fluid neurofilament light chain is associated with kynurenine pathway metabolite changes in multiple sclerosis","volume":"21","author":"Rajda","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/138161209787185751","article-title":"The importance of NAD in multiple sclerosis","volume":"15","author":"Penberthy","year":"2009","journal-title":"Curr Pharm design"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01013","article-title":"Kynurenine pathway metabolites as biomarkers for amyotrophic lateral sclerosis","volume":"13","author":"Tan","year":"2019","journal-title":"Front Neurosci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00388","article-title":"IDO and kynurenine metabolites in peripheral and CNS disorders","volume":"11","author":"Huang","year":"2020","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2174\/1389450117666161223125417","article-title":"Kynurenine system and multiple sclerosis, pathomechanism and drug targets with an emphasis on laquinimod","volume":"19","author":"Majl\u00e1th","year":"2018","journal-title":"Curr Drug Targets"},{"key":"B13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.15171\/mejdd.2018.126","article-title":"An increased level of aryl hydrocarbon receptor in patients with pancreatic cancer","volume":"11","author":"Masoudi","year":"2019","journal-title":"Middle East J digestive Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00551","article-title":"Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research","volume":"5","author":"Nguyen","year":"2014","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/NXI.0000000000000982","article-title":"Exercise diminishes plasma neurofilament light chain and reroutes the kynurenine pathway in multiple sclerosis","volume":"8","author":"Joisten","year":"2021","journal-title":"Neurol-Neuroimmunol Neuroinflamm"},{"key":"B16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbi.2015.07.016","article-title":"Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms","volume":"51","author":"Aeinehband","year":"2016","journal-title":"Brain beh Immun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(02)00710-3","article-title":"Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients","volume":"331","author":"Rejdak","year":"2002","journal-title":"Neurosci Lett"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00702-007-0667-y","article-title":"Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis","volume":"114","author":"Rejdak","year":"2007","journal-title":"J Neural Transm"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-014-0204-5","article-title":"Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies","volume":"11","author":"Sundaram","year":"2014","journal-title":"J Neuroinflamm"},{"key":"B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-71519-9_127-1","article-title":"Quinolinic acid and related excitotoxins: Mechanisms of neurotoxicity and disease relevance","volume-title":"Handbook of neurotoxicity","author":"Addae","year":"2021"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(02)00176-5","article-title":"Effect of indoleamine 2, 3-dioxygenase on induction of experimental autoimmune encephalomyelitis","volume":"129","author":"Sakurai","year":"2002","journal-title":"J neuroimmunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2015.03.002","article-title":"The kynurenine pathway and neurodegenerative disease","volume":"40","author":"Maddison","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"V\u00e9csei","year":"2013","journal-title":"Nat Rev Drug Discovery"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.42.7.640","article-title":"Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases","volume":"42","author":"Monaco","year":"1979","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4613-0381-7_30","article-title":"Serum tryptophan, kynurenine, and neopterin in patients with Guillain-barre-syndrome (GBS) and multiple sclerosis (MS)","volume-title":"Recent advances in tryptophan research","author":"Rudzite","year":"1996"},{"key":"B26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3109\/00207459608986697","article-title":"Tryptophan availability and the susceptibility to stress in multiple sclerosis: A hypothesis","volume":"86","author":"Sandyk","year":"1996","journal-title":"Int J Neurosci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-012-0765-3","article-title":"The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications","volume":"119","author":"F\u00fcvesi","year":"2012","journal-title":"J Neural Transm"},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.69035","article-title":"Serotonin in neurological diseases","volume-title":"Serotonin: A chemical messenger between all types of living cells","author":"Dorszewska","year":"2017"},{"key":"B29","doi-asserted-by":"publisher","first-page":"7905148","DOI":"10.1155\/2017\/7905148","article-title":"Oxidative modification of blood serum proteins in multiple sclerosis after interferon beta and melatonin treatment","volume":"2017","author":"Adamczyk-Sowa","year":"2017","journal-title":"Oxid Med Cell Longevity"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.03.048","article-title":"Indoleamine-2, 3-dioxygenase (IDO) 2 polymorphisms are not associated with multiple sclerosis in italians","volume":"377","author":"Agliardi","year":"2017","journal-title":"J Neurol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00157","article-title":"Host and microbial tryptophan metabolic profiling in multiple sclerosis","volume":"11","author":"Gaetani","year":"2020","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2005.00442.x","article-title":"Kynurenine metabolism in multiple sclerosis","volume":"112","author":"Hartai","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"B33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/cells8020084","article-title":"Biochemical differences in cerebrospinal fluid between secondary progressive and relapsing\u2013remitting multiple sclerosis","volume":"8","author":"Herman","year":"2019","journal-title":"Cells"},{"key":"B34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1191\/1352458505ms1127oa","article-title":"Immunological heterogeneity of multiple sclerosis in Sardinia and Sweden","volume":"11","author":"Huang","year":"2005","journal-title":"Multiple Sclerosis J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601139","article-title":"Amino acid catabolism in multiple sclerosis affects immune homeostasis","volume":"198","author":"Negrotto","year":"2017","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-015-0437-7","article-title":"EBV and vitamin d status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature","volume":"205","author":"Nejati","year":"2016","journal-title":"Med Microbiol Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.661493","article-title":"Serum short-chain fatty acids and associations with inflammation in newly diagnosed patients with multiple sclerosis and healthy controls","volume":"12","author":"Olsson","year":"2021","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2013.08.009","article-title":"Oxidative modification of serum proteins in multiple sclerosis","volume":"63","author":"Sadowska-Bartosz","year":"2013","journal-title":"Neurochem Int"},{"key":"B39","doi-asserted-by":"publisher","first-page":"113246","DOI":"10.1016\/j.jpba.2020.113246","article-title":"A validated UHPLC-MS method for tryptophan metabolites: Application in the diagnosis of multiple sclerosis","volume":"185","author":"T\u00f6m\u00f6si","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"B40","doi-asserted-by":"publisher","first-page":"103662","DOI":"10.1016\/j.msard.2022.103662","article-title":"Urine neopterin in childhood acute demyelinating diseases: Potential for differential diagnosis","volume":"59","author":"Kayao\u011flu","year":"2022","journal-title":"Multiple sclerosis related Disord"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01844-y","article-title":"Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression","volume":"17","author":"Sundaram","year":"2020","journal-title":"J Neuroinflamm"},{"key":"B42","doi-asserted-by":"publisher","first-page":"41473","DOI":"10.1038\/srep41473","article-title":"Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression","volume":"7","author":"Lim","year":"2017","journal-title":"Sci Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00246","article-title":"Current evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosis","volume":"7","author":"Lovelace","year":"2016","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160818270","article-title":"Kynurenines and multiple sclerosis: The dialogue between the immune system and the central nervous system","volume":"16","author":"Rajda","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2016.03.024","article-title":"Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases","volume":"112","author":"Lovelace","year":"2017","journal-title":"Neuropharmacology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0165-5728(88)90160-9","article-title":"On the immunopathology of plaque development and repair in multiple sclerosis","volume":"20","author":"Raine","year":"1988","journal-title":"J neuroimmunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.6.3750","article-title":"Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis","volume":"181","author":"O'Connor","year":"2008","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1179\/135100000101535375","article-title":"Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis","volume":"5","author":"Guillemin","year":"2000","journal-title":"Redox Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1007\/s00213-019-05200-8","article-title":"Inflammation in cancer and depression: A starring role for the kynurenine pathway","volume":"236","author":"Sforzini","year":"2019","journal-title":"Psychopharmacology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2, 3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J Exp Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00915.x","article-title":"Control of immune response by amino acid metabolism","volume":"236","author":"Grohmann","year":"2010","journal-title":"Immunol Rev"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401073","article-title":"T Cell apoptosis by tryptophan catabolism","volume":"9","author":"Fallarino","year":"2002","journal-title":"Cell Death Differentiation"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-006700","article-title":"The tryptophan catabolite l-kynurenine inhibits the surface expression of NKp46-and NKG2D-activating receptors and regulates NK-cell function","volume":"108","author":"Chiesa","year":"2006","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020052","article-title":"Inhibition of allogeneic T cell proliferation by indoleamine 2, 3-dioxygenase\u2013expressing dendritic cells: mediation of suppression by tryptophan metabolites","volume":"196","author":"Terness","year":"2002","journal-title":"J Exp Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1089\/107999001317205231","article-title":"IFN-\u03b2 1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment","volume":"21","author":"Guillemin","year":"2001","journal-title":"J Interferon Cytokine Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2005.01041.x","article-title":"Interferon-\u03b2 affects the tryptophan metabolism in multiple sclerosis patients","volume":"12","author":"Amirkhani","year":"2005","journal-title":"Eur J Neurol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200312190-00005","article-title":"A\u03b21-42 induces production of quinolinic acid by human macrophages and microglia","volume":"14","author":"Guillemin","year":"2003","journal-title":"Neuroreport"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5032-08.2009","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 mediate the upregulation of indoleamine 2, 3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus calmette-guerin","volume":"29","author":"O'Connor","year":"2009","journal-title":"J Neurosci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/135502801300069692","article-title":"Quinolinic acid is produced by macrophages stimulated by platelet activating factor, nef and tat","volume":"7","author":"Smith","year":"2001","journal-title":"J neurovirol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2017.05.002","article-title":"The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO","volume":"35","author":"Mondanelli","year":"2017","journal-title":"Curr Opin Pharmacol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01565","article-title":"Immunoregulatory interplay between arginine and tryptophan metabolism in health and disease","volume":"10","author":"Mondanelli","year":"2019","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nri2163","article-title":"IDO and regulatory T cells: A role for reverse signalling and non-canonical NF-\u03baB activation","volume":"7","author":"Puccetti","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.2004.04446.x","article-title":"pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I","volume":"271","author":"Han","year":"2004","journal-title":"Eur J Biochem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"S4294","DOI":"10.4137\/IJTR.S4294","article-title":"Understanding the roles of the kynurenine pathway in multiple sclerosis progression","volume":"3","author":"Lim","year":"2010","journal-title":"Int J Tryptophan Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1159\/000086295","article-title":"Age-related increase of kynurenic acid in human cerebrospinal fluid\u2013IgG and \u03b22-microglobulin changes","volume":"14","author":"Kepplinger","year":"2005","journal-title":"Neurosignals"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(88)90813-0","article-title":"The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection","volume":"90","author":"Andin\u00e9","year":"1988","journal-title":"Neurosci Lett"},{"key":"B67","doi-asserted-by":"publisher","first-page":"S13256","DOI":"10.4137\/IJTR.S13256","article-title":"Sustained elevation of kynurenic acid in the cerebrospinal fluid of patients with herpes simplex virus type 1 encephalitis","volume":"6","author":"Atlas","year":"2013","journal-title":"Int J Tryptophan Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J Affect Disord"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2007.01.033","article-title":"Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders","volume":"257","author":"Sas","year":"2007","journal-title":"J neurol Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4101-07.2007","article-title":"Characterization of the kynurenine pathway in human neurons","volume":"27","author":"Guillemin","year":"2007","journal-title":"J Neurosci"},{"key":"B71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ics.2007.07.011","article-title":"Characterization of the kynurenine pathway in human oligodendrocytes","volume-title":"International congress series","author":"Lim","year":"2007"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(01)02017-0","article-title":"Oligodendrocyte killing by quinolinic acid in vitro","volume":"896","author":"Cammer","year":"2001","journal-title":"Brain Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn119","article-title":"Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"131","author":"Anderson","year":"2008","journal-title":"Brain"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.6.3283","article-title":"The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1\u03b1 and-1\u03b2 in macrophages","volume":"164","author":"Bosco","year":"2000","journal-title":"J Immunol"},{"key":"B75","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.150.9.4031","article-title":"Picolinic acid, a catabolite of l-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages","volume":"150","author":"Melillo","year":"1993","journal-title":"J Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)37169-7","article-title":"Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acid","volume":"269","author":"Melillo","year":"1994","journal-title":"J Biol Chem"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: A paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J neurochem"},{"key":"B78","doi-asserted-by":"publisher","first-page":"S2469","DOI":"10.4137\/IJTR.S2469","article-title":"The physiological action of picolinic acid in the human brain","volume":"2","author":"Grant","year":"2009","journal-title":"Int J Tryptophan Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1013784\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T23:29:15Z","timestamp":1678490955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1013784\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":78,"alternative-id":["10.3389\/fimmu.2022.1013784"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1013784","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"article-number":"1013784"}}